TAK insider trading — Takeda Pharmaceutical Co Ltd
Over the last 90 days, insiders at Takeda Pharmaceutical Co Ltd (TAK) made 0 open-market purchases worth $0 and 16 open-market sales worth $10.58M, making them net sellers by $10.58M. The largest sale was by Plump Andrew Stewart (President, R&D), who sold 165,393 shares for $2.83M on Aug 10, 2026.
Updated Oct 16, 2026.
Recent TAK insider transactions
Every Form 4 filed by Takeda Pharmaceutical Co Ltd officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Duprey Lauren Rusckowski | Chief Transformation Officer | S · Sale | Direct | 34,535 | $18.54 | $640K | Form 4 |
| Sep 2, 2026 | Plump Andrew Stewart | President, R&D | S · Sale · 10b5-1 | Indirect | 116,191 | $18.49 | $2.15M | Form 4 |
| Aug 19, 2026 | Plump Andrew Stewart | President, R&D | S · Sale · 10b5-1 | Indirect | 19,651 | $18.49 | $363K | Form 4 |
| Aug 18, 2026 | Greenway Nicola Deidre Petal | Chief Human Resources Officer | S · Sale | Direct | 12,980 | $18.11 | $235K | Form 4 |
| Aug 10, 2026 | Farajallah Awny Samaan Botros | Chief Medical Officer | S · Sale | Direct | 14,006 | $17.10 | $240K | Form 4 |
| Aug 10, 2026 | Ibrahim Ramy Riad Ahmed | President, PDT BU | S · Sale | Direct | 7,277 | $17.10 | $124K | Form 4 |
| Aug 10, 2026 | Pacheco Rhonda Janice | President, U.S. Business Unit | S · Sale | Direct | 16,901 | $17.10 | $289K | Form 4 |
| Aug 10, 2026 | Duprey Lauren Rusckowski | Chief Transformation Officer | S · Sale | Direct | 47,586 | $17.10 | $814K | Form 4 |
| Aug 10, 2026 | Plump Andrew Stewart | President, R&D | S · Sale | Direct | 165,393 | $17.10 | $2.83M | Form 4 |
| Aug 10, 2026 | Pignagnoli Agosti Marcello | Head, Strat. & Port. Dev | S · Sale | Direct | 22,957 | $17.10 | $393K | Form 4 |
| Aug 10, 2026 | Bitetti Teresa Marie | President, OBU | S · Sale | Direct | 50,012 | $17.10 | $855K | Form 4 |
| Aug 10, 2026 | Shannon Elaine Mary | Pres., Global Supply & Quality | S · Sale | Direct | 3,978 | $17.10 | $68K | Form 4 |
| Aug 10, 2026 | Ricci Gabriele | Chief Data & Tech. Officer | S · Sale | Direct | 25,088 | $17.10 | $429K | Form 4 |
| Aug 10, 2026 | Greenway Nicola Deidre Petal | Chief Human Resources Officer | S · Sale | Direct | 41,377 | $17.44 | $722K | Form 4 |
| Aug 10, 2026 | Kim Julie So-Young | President and CEO | S · Sale | Direct | 89,090 | $17.10 | $1.52M | Form 4 |
| Aug 10, 2026 | Platford Giles Richard | President, IBU | S · Sale | Direct | 31,083 | $17.10 | $532K | Form 4 |
| Aug 10, 2026 | Furney Natalie Anne Marie | Global General Counsel | S · Sale | Direct | 30,868 | $17.10 | $528K | Form 4 |
| Aug 11, 2026 | Shannon Elaine Mary | Pres., Global Supply & Quality | S · Sale | Direct | 20,363 | $17.55 | $357K | Form 4 |
TAK insider trading FAQ
Are insiders buying TAK stock?
Not on the open market. In the last 90 days, Takeda Pharmaceutical Co Ltd insiders made no open-market purchases, and 16 open-market sales totaling $10.58M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading TAK?
Recent sellers: Bitetti Teresa Marie, Duprey Lauren Rusckowski, Farajallah Awny Samaan Botros, Furney Natalie Anne Marie, Greenway Nicola Deidre Petal, Ibrahim Ramy Riad Ahmed.
Where does TAK insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.